Magnetic Resonance Evaluation of Multiple Myeloma at 3.0 Tesla: How Do Bone Marrow Plasma Cell Percentage and Selection of Protocols Affect Lesion Conspicuity?
Overview
Authors
Affiliations
Purpose: To compare various pulse sequences in terms of percent contrast and contrast-to-noise ratio (CNR) for detection of focal multiple myeloma lesions and to assess the dependence of lesion conspicuity on the bone marrow plasma cell percent (BMPC%).
Materials And Methods: Sagittal T1-weighted FSE, fat-suppressed T2-weighted FSE (FS- T2 FSE), fast STIR and iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL) imaging of the lumbar spine were performed (n = 45). Bone marrow (BM)-focal myeloma lesion percent contrast and CNR were calculated. Spearman rank correlation coefficients were obtained between percent contrast, CNR and BMPC%. Percent contrasts and CNRs were compared among the three imaging sequences.
Results: BM-focal lesion percent contrasts, CNRs and BMPC% showed significant negative correlations in the three fat-suppression techniques. Percent contrast and CNRs were significantly higher for FS- T2 FSE than for STIR (P<0.01, P<0.05, respectively), but no significant differences were found among the three fat-suppression methods in the low tumor load BM group.
Conclusion: The higher BMPC% was within BM, the less conspicuous the focal lesion was on fat-suppressed MRI. The most effective protocol for detecting focal lesions was FS- T2 FSE. In the high tumor load BM group, no significant differences in lesion conspicuity were identified among the three fat-suppression techniques.
Whole body MRI in multiple myeloma: Optimising image acquisition and read times.
Singh S, Pilavachi E, Dudek A, Bray T, Latifoltojar A, Rajesparan K PLoS One. 2020; 15(1):e0228424.
PMID: 31999774 PMC: 6992198. DOI: 10.1371/journal.pone.0228424.
Diagnostic utility of whole body Dixon MRI in multiple myeloma: A multi-reader study.
Bray T, Singh S, Latifoltojar A, Rajesparan K, Rahman F, Narayanan P PLoS One. 2017; 12(7):e0180562.
PMID: 28672007 PMC: 5495520. DOI: 10.1371/journal.pone.0180562.